The COVID-19 pandemic started from World’s manufacturing hub China, has been continuously spreading across the globe, so far more than 218 countries are affected with COVID-19. The COVID-19 pandemic started in 2019, had worldwide footprints in 2020, which led the governments to take severe actions such as social distancing, complete lockdown, and no trade among countries, etc. in many regions including European Union, North America, Asia Pacific, Latin America, and Middle East and Africa has put a brake on the tremendous growth trajectory of the world GDP in the last decade and impacted trillions of dollars of revenues. The world GDP increased around 32% during the previous decade and reached US$ 87.26 Tn in 2019 has seen rapid demand declines and recession fears around the world.
According to a report by the International Monetary Fund (IMF) published in 2020, the world GDP is projected to decrease by around 3.0% in 2020. Moreover, as per the same report, the developed economies is projected to have more severe losses as compared to developing economies. In 2019, the advanced economies has seen a growth of 1.7% and developing economies has seen growth of 3.7% but due to COVID-19 IMF projected that developing economies will see a decline of around 1.0% whereas developed economies will see decline of over 6.0% in 2020. Besides, with the progress on vaccination worldwide along with the extraordinary policy support the world economy started to emerge from the nastiest phase of the COVID-19 pandemic.
To reduce the revenue losses of our clients across the globe, Constancy Researchers Private Limited provide a dedicated COVID-19 section in the each and every report which includes COVID-19 Prevalence Analysis, COVID-19 Vaccine Analysis, COVID-19 Impact on Global Market, Pre vs Post COVID Demand and Supply Analysis, COVID-19 Road to Recovery Analysis, COVID-19 impact on End-user Industry, COVID-19 Opportunity Analysis etc.
To know how COVID-19 is impacting your business and your revenues, please fill the form and schedule a call with our analyst
COVID-19 Road to Recovery Analysis
